Amalgamated Bank’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,747
| Closed | -$122K | – | 2998 |
|
|
2024
Q3 | $122K | Hold |
1,747
| – | – | ﹤0.01% | 1675 |
|
|
2024
Q2 | $117K | Buy |
1,747
+69
| +4% | +$4.65K | ﹤0.01% | 1689 |
|
|
2024
Q1 | $116K | Sell |
1,678
-5,374
| -76% | -$363K | ﹤0.01% | 1700 |
|
|
2023
Q4 | $439K | Sell |
7,052
-499
| -7% | -$27.9K | ﹤0.01% | 1492 |
|
|
2023
Q3 | $424K | Buy |
7,551
+82
| +1% | +$4.61K | ﹤0.01% | 1487 |
|
|
2023
Q2 | $377K | Buy |
7,469
+566
| +8% | +$30.1K | ﹤0.01% | 1571 |
|
|
2023
Q1 | $377K | Sell |
6,903
-1,157
| -14% | -$67.6K | ﹤0.01% | 1549 |
|
|
2022
Q4 | $504K | Buy |
8,060
+129
| +2% | +$8.56K | ﹤0.01% | 1462 |
|
|
2022
Q3 | $559K | Buy |
7,931
+492
| +7% | +$33.9K | 0.01% | 1375 |
|
|
2022
Q2 | $422K | Sell |
7,439
-63
| -0.8% | -$3.45K | ﹤0.01% | 1540 |
|
|
2022
Q1 | $470K | Sell |
7,502
-563
| -7% | -$30.3K | ﹤0.01% | 1577 |
|
|
2021
Q4 | $452K | Sell |
8,065
-80
| -1% | -$4.89K | ﹤0.01% | 1626 |
|
|
2021
Q3 | $530K | Buy |
8,145
+284
| +4% | +$19.4K | ﹤0.01% | 1547 |
|
|
2021
Q2 | $498K | Buy |
7,861
+3,562
| +83% | +$210K | ﹤0.01% | 1642 |
|
|
2021
Q1 | $257K | Sell |
4,299
-428
| -9% | -$23.3K | 0.01% | 1345 |
|
|
2020
Q4 | $236K | Buy |
4,727
+22
| +0.5% | +$1.03K | 0.01% | 1359 |
|
|
2020
Q3 | $240K | Buy |
+4,705
| New | +$196K | 0.01% | 1232 |
|
Other funds holding AXNX
Amalgamated Bank's AXNX Position: Q4 2024 in Review
Amalgamated Bank sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 1,747 shares — an estimated $122K sold.
Amalgamated Bank first reported a position in AXNX in Q3 2020 and held it in 17 quarters. The position peaked at $559K in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.
- Amalgamated Bank reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Amalgamated Bank sold 1,747 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $122K.
- Amalgamated Bank first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 17 quarters.
- Amalgamated Bank's Axonics, Inc. Common Stock position peaked at $559K in Q3 2022.
- 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.
Based on Amalgamated Bank's 13F filing for Q4 2024, filed 4 Feb 2025.